To investigate the impact of the national centralized procurement policies (referred to as centralized procurement below) on the use of insulin in public hospitals.
Using descriptive statistical analysis and interrupted time series analysis, the national implementation of insulin centralized procurement was taken as the policy intervention point to analyze the changes in sales amount, sales volume, and average daily usage cost of insulin in sample hospitals before and after the centralized procurement from 2017 Q1 (each year is divided into four quarters, which are commonly referred to as Q1, Q2, Q3, and Q4, respectively) to 2023 Q3.
After centralized procurement, the sales trend of different types of insulin changed differently, with second-generation and foreign-funded brand insulin showing a downward trend, and third-generation and domestic brand insulin showing an upward trend. The sales amount of different types of insulin decreased, and the average daily use cost had obvious breakpoints and decreased significantly.
Centralized procurement effectively controlled the costs of insulin, promoted the iteration of insulin use, altered the brand usage landscape, and significantly reduced the drug burden of patients.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |